Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.
Open Access
- 1 November 1990
- journal article
- research article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 111 (5) , 2129-2138
- https://doi.org/10.1083/jcb.111.5.2129
Abstract
The fibroblast or heparin-binding growth factors (HBGFs) are thought to be modulators of cell growth and migration, angiogenesis, wound repair, neurite extension, and mesoderm induction. A better understanding of the structural basis for the different activities of these proteins should facilitate the development of agonists and antagonists of specific HBGF activities and identification of the signal transduction pathways involved in the mechanisms of action of these growth factors. Chemical modification studies of Harper and Lobb (Harper, J. W., and R. R. Lobb. 1988. Biochemistry. 27:671-678) implicated lysine 132 in HBGF-1 (acid fibroblast growth factor) as being important to the heparin-binding, receptor-binding, and mitogenic activities of the protein. We changed lysine 132 to a glutamic acid residue by site-directed mutagenesis of the human cDNA and expressed the mutant protein in Escherichia coli to obtain sufficient quantities for functional studies. Replacement of this lysine with glutamic acid reduces the apparent affinity of HBGF-1 for immobilized heparin (elutes at 0.45 M NaCl vs. 1.1 M NaCl for wild-type). Mitogenic assays established two points: (a) human recombinant HBGF-1 is highly dependent on the presence of heparin for optimal mitogenic activity, and (b) the change of lysine 132 to glutamic acid drastically reduces the specific mitogenic activity of HBGF-1. The poor mitogenic activity of the mutant protein does not appear to be due to a reduced affinity for the HBGF receptor. Similary, the mutant HBGF-1 can stimulate tyrosine kinase activity and induce protooncogene expression. Differences in the biological properties of the wild-type and mutant proteins were observed in transfection studies. Mutant HBGF-1 expression in transfected NIH 3T3 cells did not induce the same transformed phenotype characteristic of cells expressing wild-type HBGF-1. Together these data indicate that different functional properties of HBGF-1 may be dissociated at the structural level.This publication has 46 references indexed in Scilit:
- Recent developments in the cell biology of basic fibroblast growth factor.The Journal of cell biology, 1989
- THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINSAnnual Review of Biochemistry, 1989
- A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGFNature, 1988
- Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells.The Journal of cell biology, 1988
- Thrombin inactivates acidic fibroblast growth factor but not basic fibroblast growth factorBiochemistry, 1988
- Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitroBiochemical and Biophysical Research Communications, 1988
- Reductive methylation of lysine residues in acidic fibroblast growth factor: effect on mitogenic activity and heparin affinityBiochemistry, 1988
- Structure activity relationship in heparin: Stimulation of non-vascular cells by a synthetic heparin pentasaccharide in cooperation with human acidic fibroblast growth factorsBiochemical and Biophysical Research Communications, 1986
- Isolation of an amino terminal extended form of basic fibroblast growth factorBiochemical and Biophysical Research Communications, 1986
- Tumorigenesis by mouse mammary tumor virus: Proviral activation of a cellular gene in the common integration region int-2Cell, 1984